MetaCap

DarioHealth Corp. (DRIO)

NASDAQ: DRIOHealth CareMedical/Dental InstrumentsUSD

1.32-0.12 (-8.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

DRIO stock chart

Technical analysis

Key statistics

All statistics
Market cap
$14.90M
EPS (TTM)
-$3.53
52-week range
1.09 – 14.49
Day range
1.26 – 1.65
Volume / Avg
28.21K / 48.52K
Beta
—

52-week range

$1.09$14.49

DRIO stock today

On Nov 20, DRIO ended the session at $1.32, shedding $0.12 (8.33%), versus the S&P 500's 3.70% decline. At this level, DRIO sits near the bottom of its 52-week range of $1.09 to $14.49: 90.9% below the high, set on Nov 24, 2025 and 21.1% above the low. DRIO is down 88.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 90.5%.

DarioHealth has posted a net loss over the last twelve months (EPS of -$3.53), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About DarioHealth

Company profile

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Industry
Medical/Dental Instruments
CEO
Mr. Erez Raphael
Headquarters
New York, NY
Employees
160

Financial highlights

Full financials

In fiscal 2025, DarioHealth generated $22.4 million in revenue, down 17.3% from fiscal 2024, its first annual decline since 2023. DarioHealth reported a net loss of $41.7 million, compared with a loss of $42.7 million a year earlier. Gross margin was 56.6% (up from 49.1%) and operating margin -163.9%.

DarioHealth annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$22.36M$27.04M$20.35M$27.66M$20.51M
Growth-17.31%+32.86%-26.41%+34.82%+170.76%
Net income$-41.71M$-42.75M$-59.43M$-62.19M$-76.76M
EPS (diluted)$10.12$12.27$1.93$2.54$4.07

Analyst forecast

Forecast

Consensus (5 analysts)

strong_buy

Avg. price target

$13.60+930.30%

  • Strong buy 0
  • Buy 4
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $8.00High $28.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$0.73 vs $-0.68
Surprise
+207.35%

DRIO news

All DRIO news

DarioHealth peers

Health Care sector
DRIO peer companies
CompanyPrice% ChgMarket capCompare
CVRXCVRx Inc.0.501-5.99%$14.27Mvs DRIO
MODDModular Medical Inc.1.68-11.81%$16.36Mvs DRIO
CTSOCytosorbents Corporation4.16-18.91%$13.12Mvs DRIO
RVPRetractable Technologies Inc.0.558-6.84%$16.70Mvs DRIO
SNWVSANUWAVE Health Inc.1.50-5.66%$12.90Mvs DRIO
BEATHeartbeam Inc.0.2751-10.94%$17.42Mvs DRIO
PMIPicard Medical Inc.6.79+7.78%$18.07Mvs DRIO
GUTSFractyl Health Inc.0.82-14.16%$10.88Mvs DRIO

Indexes, lists and sector

DarioHealth stock FAQ

What is DarioHealth's stock price today?

DRIO last traded at $1.32 as of Nov 20, 4:00 PM EST, down 8.33% on the day. Prices are delayed at least 15 minutes.

Does DarioHealth pay a dividend?

No. DarioHealth does not currently pay a regular cash dividend.

Who is DarioHealth's CEO?

Mr. Erez Raphael is the chief executive officer of DarioHealth Corp., which has about 160 employees.

Has DRIO ever split its stock?

Yes. The most recent DRIO stock split was a 1-for-20 split on Aug 28, 2025.

What is the DRIO 52-week high?

The 52-week high for DRIO is $14.49 and the 52-week low is $1.09. The stock is currently 90.9% below its high.

Compare DRIO